Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A.
Saved in:
| Title: | Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A. |
|---|---|
| Authors: | Xue, Feng1 (AUTHOR), Zhao, Xielan2 (AUTHOR), Sun, Jing3 (AUTHOR), Zeng, Xiaojing4 (AUTHOR), Yang, Fenge5 (AUTHOR), Xu, Ming6 (AUTHOR), Yu, Ziqiang7 (AUTHOR), Gu, Weiying8 (AUTHOR), Feng, Ying9 (AUTHOR), Li, Wenqian10 (AUTHOR), Zheng, Changcheng11 (AUTHOR), Bi, Hui12 (AUTHOR), Xie, Liangzhi13 (AUTHOR), Gai, Wenlin13 (AUTHOR), Yang, Renchi1 (AUTHOR) rcyang65@163.com |
| Source: | Haemophilia. Sep2021, Vol. 27 Issue 5, p814-822. 9p. 1 Diagram, 5 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
